Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number	Program Official
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Early detection of colorectal cancer in the traditional and serrated pathways	5R01CA249851-05	Guillermo Marquez, Ph.D.
Zhu, Yazhen	University Of California Los Angeles United States	Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma	5R01CA255727-05	Matthew Young, Ph.D.
Li, Bo	Children'S Hosp Of Philadelphia United States	Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis	5R01CA258524-06	Christos Patriotis, Ph.D., M.Sc.
Spellman, Paul T.	University Of California Los Angeles United States	Germline Determinants of Prostate Cancer Evolution	5R01CA270108-03	Guillermo Marquez, Ph.D.
Mallick, Parag Kumar	Stanford University United States	Pathomic Predictors of Prostate Cancer Progression	5R01CA249899-05
Liu, Yang	University Of Illinois At Urbana-Champaign United States	Imaging nanoscale chromatin folding in early carcinogenesis	5R01CA254112-07	Matthew Young, Ph.D.
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-05	Guillermo Marquez, Ph.D.
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Li, Feng	University Of California Los Angeles United States	Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.	5R21CA283665-02	Guillermo Marquez, Ph.D.
Bettegowda, Chetan	Johns Hopkins University United States	Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid	5R37CA230400-07	Sidney Fu, M.D.
Wang, Tza-Huei Jeff	Johns Hopkins University United States	A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies	5R33CA272321-03	Christos Patriotis, Ph.D., M.Sc.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05	Matthew Young, Ph.D.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05